|
王榮德(2016)。長期使用呼吸機維生之抉擇。臺灣醫界,l59(3)。 白佳原、王銘雄(2007)。皮膚科雷射儀器成本分析及定價影響模式。中山醫學雜誌,18,79-87。 朱僑麗(2008)。臺灣高科技醫療儀器採用情形與國際之比較。中華民國醫院協會雜誌,31,17-22。 余珮蓉、曾琦琳(2008)。降低加護病房呼吸機耗損率之改善專案。志為護理,7(6),83-93。 吳清平(2012)。台灣吸呼器長期使用概況。醫療爭議審議報導系列,51。 李一鑫(2010)。醫院購置高科技醫療儀器與市場結構的關聯。未出版之碩士論文,國立中央大學產業經濟研究所,桃園市。 李隆生(2000)。影響醫院購置昂貴醫療儀器決策之因素-以臺南高雄兩地醫院為例。中華公共衛生雜誌,18,327-333。 岳詩萍(2017)。新生兒聽力篩檢流程之研究-採用醫療照護失效模式與效應分析。未出版之碩士論文,私立南臺科技大學企業管理系研究所,臺南市。 張太賓(2007)。運用流程再造及壽期成本分析於設備採購決策模式之研究。未出版之碩士論文,國立屏東科技大學高階經營管理研究所,屏東縣。 許意敏(2013)。運用失效模式與效應分析評估接受磁振造影檢查之病患安全性。未出版之碩士論文,私立中臺科技大學醫學影像暨放射科學系暨研究所,臺中市。 陳佳伶(2016)。應用「醫療照護失效模式與效應分析」以防範腫瘤標誌檢驗錯誤報告。健康管理學刊,14(1),1-17。 陳啟政、鄭文英、梁書銘(2008)。結合FMEA技術與壽期成本分析於最佳化設備採購策略之研究。國科會專題研究計畫編號NSC-97-2221-E-020-020-MY2。 陳培中(2007)。臺灣獸醫醫療市場演變與趨勢分析。中他藥訊,69,30-33。 曾靖雅(2008)。64切螺旋電腦斷層掃描儀成本效益分析-以中部某區域教學醫院為例。未出版之碩士論文,私立義守大學醫務管理系研究所,高雄市。 楊明璧、吳信宏(2002)。醫院貴重儀器投資及更新之決策模式。醫務管理期刊,3,81-103。 楊長興、林家瑾、陳楚杰(2001)。醫療新科技評估-美國論述。醫院,34,1-7。 管玉貞(1984)。中心診所醫院放射科使用電腦斷層機三年另五個月之病例統計。中華放射醫誌,9,181-183。 趙建革、郭妍(2007)。醫療設備的效益分析及成本核算。中外醫療,21,55。 劉彩娥(2010)。運用醫療失效模式與效應分析於呼吸管路安全之改善。未出版之碩士論文,私立中臺科技大學醫護管理研究所,臺中市。 蔡文正、龔佩珍、楊志良、江怡如(2005)。臺灣高科技醫療儀器之利用趨勢(1998-2001年)。醫務管理期刊,6,446-460。 蔡佳吟(2006)。醫療院所醫療儀器採購決策支援系統之建構與評估。未出版之碩士論文,私立長榮大學醫務管理學研究所,臺南市。 蔡偉德、李一鑫(2002)。醫院非價格性競爭與市場結構:醫院購置高科技醫療儀器之實證研究。經濟論文,30,57-78。 鄭哲舟(2010)。以HFMEA改善對癌症住院病人施行化學治療的流程-以台灣某區域教學醫院為例。未出版之碩士論文,國立成功大學高階管理碩士在職專班,臺南市。 謝其慶(2017)。醫院經營策略與績效管理。高雄長庚紀念醫院演講資料。 魏璽倫(1997)。臺北市市立醫院申購昂貴醫療儀器審查制度之評估與改善芻議。未出版之碩士論文,國立臺灣大學醫療機構管理研究所,臺北市。 蘇一峰(2017年6月3日)。別等插管後才後悔,重要!這5種病人一但插管,往往一直插到過世為止。良醫健康網,取自http://tvgh-suvy.blogspot.com/2017/06/5.html Ahmed, K., Khan, N., Khan, M. S., & Dasgupta, P. (2013). Development and content validation of a surgical safety checklist for operating theatres that use robotic technology. BJU international, 111(7), 1161-74. Bell, R. A. (1996). Economics of MRI technology. Journal of Magnetic Resonance Imaging, 6(1), 10-25. Bhalla, T., Dairo, O. O., Martin, D., Wrona, S., Fetzer, M., & Taghon, T., et al. (2014). A proactive risk assessment by utilizing ‘Healthcare Failure Mode and Effect Analysis’ (HFMEA) for safe implementation of peripheral nerve catheters in pediatric patients. Anaesth Pain & Intensive Care, 18(1), 21-4. Bond, T. C. (1995). The Role of Performance Measurement in Continuous Improvement. International Journal Operation & Production Management, 48(4), 14-15. Cagliano, A. C., Grimaldi, S, & Rafele, C. (2011). A systemic methodology for risk management in healthcare sector. Safety Science, 49(5), 695-708. Carroll, R. (Ed.). (2009). Risk management handbook for health care organizations (Vol. 30). John Wiley & Sons. Cassanelli, G., Mura, G., Fantini, F., Vanzi, M., & Plano, B. (2006). Failure analysis-assisted FMEA. Microelectronics Reliability, 46(9-11), 1795-1799. Chen, I. J., Paulraj, A., & Lado, A. A. (2004). Strategic purchasing, supply management, and firm performance. Journal of operations management, 22(5), 505-523. Cheng, C. H., Chou, C. J., Wang, P. C., Lin, H. Y., Kao, C. L., & Su, C. T. (2012). Applying HFMEA to prevent chemotherapy errors. Journal of medical systems, 36(3), 1543-1551. Cronrath, P., Lynch, T. W., Gilson, L. J., Nishida, C., Sembar, M. C., Spencer, P. J., & West, D. F. (2011). PCA Oversedation: Application Of Healthcare Failure Mode Effect Analysis (HFMEA (TM)). Nursing Economics, 29(2), 79. DeRosier, J., Stalhandske, E., Bagian, J. P., & Nudell, T. (2002). Using health care failure mode and effect analysis™: the VA National Center for Patient Safety’s prospective risk analysis system. The Joint Commission journal on quality improvement, 28(5), 248-267. Dong, C. (2007). Failure mode and effects analysis based on fuzzy utility cost estimation. International Journal of Quality & Reliability Management, 24(9), 958-971. Ellram, L. M., & Liu, B. (2002). The financial IMPACT of supply management. SUPPLY CHAIN MANAGEMENT REVIEW, 6(6), 30-37. Enkawa, T. (1998). Production Efficiency Paradigms: Interrelationship Among 3T: TPM, TQC/TQM and TPS (JIT), 98. World Class Manufacturing & JIPM TPM Conference, Singapore, Mar. Greene, J. K., & Metwalli, A. (2001). The impact of activity based cost accounting on health care capital investment decisions. Journal of health care finance, 28(2), 50-64. Johnston, M., Arora, S., Anderson, O., King, D., Behar, N., & Darzi, A. (2015). Escalation of care in surgery: a systematic risk assessment to prevent avoidable harm in hospitalized patients. Annals of surgery, 261(5), 831-838. Mearig, T., Coffee, N., & Morgan, M. (1999). Life cycle cost analysis handbook: draft. State of Alaska, Department of Education and Early Development, Education Support Services/Facilities Presutti Jr, W. D. (1992). The single source issue: US and Japanese sourcing strategies. International Journal of Purchasing and Materials Management, 28(1), 2-9. Ramesh, M. (2003). Want to Trim Costs? :Strategic Sourcing Can Help a Company Manage its Supply Aspects Effectively and Thus Keep Costs Down. Want to Give it a Try? Businessline. Reiboldt, M. (2006). The future of health care policy. The Journal of medical practice management: MPM, 57-60. Singh, D., & Tiong, R. L. (2005). Development of life cycle costing framework for highway bridges in Myanmar. International Journal of Project Management, 23(1), 37-44. Teng, S. H. G., & Ho, S. Y. M. (1996). Failure Mode and Effects Analysis - An Integrated Approach for Product Design and Process Control. International Journal of Quality and Reliability Management, 13(5), 8-26. Teoh, P. C., & Case, K. (2004). Failure modes and effects analysis through knowledge modelling. Journal of Materials Processing Technology, 153, 253-260. Vogtländer, J. G., Bijma, A., & Brezet, H. C. (2002). Communicating the eco-efficiency of products and services by means of the eco-costs/value model. Journal of cleaner production, 10(1), 57-67. Yarmohammadian, M. H., Abadi, T. N. B., Tofighi, S., & Esfahani, S. S. (2014). Performance improvement through proactive risk assessment: Using failure modes and effects analysis. Journal of education and health promotion, 3. Taleghani, Y. M., Vejdani, M., Vahidi, S., Ghorat, F., & Raeisi, A. R. (2018). Application of prospective approach of healthcare failure mode and effect analysis in the risk assessment of healthcare systems. EurAsian Journal of BioSciences, 12(1), 95-104.
|